Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$338M |
| 2 |
Visa
V
|
+$279M |
| 3 |
Microsoft
MSFT
|
+$277M |
| 4 |
Union Pacific
UNP
|
+$277M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$440M |
| 2 |
Palo Alto Networks
PANW
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$281M |
| 4 |
Cognizant
CTSH
|
+$280M |
| 5 |
CrowdStrike
CRWD
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.23% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Arbutus Biopharma
ABUS
$923M
| $106K | ﹤0.01% |
45,359
+7,394
| +19% | +$17.7K |
|
|
LNAI
3677
Lunai Bioworks
LNAI
$10.9M
| $104K | ﹤0.01% |
1,268
| – | – |
|
3678
Pulmonx
LUNG
$97.1M
| $104K | ﹤0.01% |
12,369
-1,455
| -11% | -$13.8K |
|
|
UXIN
3679
Uxin Ltd
UXIN
$257M
| $104K | ﹤0.01% |
3,615
-414
| -10% | -$14.9K |
|
|
RDNW
3680
RideNow Group
RDNW
$251M
| $103K | ﹤0.01% |
+15,902
| New | +$172K |
|
|
ACB
3681
Aurora Cannabis
ACB
$216M
| $102K | ﹤0.01% |
11,042
+847
| +8% | +$10.1K |
|
3682
State Street SPDR S&P 500 ETF Trust
SPY
$807B
| $102K | ﹤0.01% |
+266
| New | +$102K |
|
3683
Skillsoft
SKIL
$84.4M
| $102K | ﹤0.01% |
3,909
-5
| -0.1% | -$167 |
|
|
CBD
3684
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $101K | ﹤0.01% |
32,660
-17,695
| -35% | -$64.3K |
|
3685
Dakota Gold
DC
$844M
| $101K | ﹤0.01% |
33,137
+12,413
| +60% | +$42.3K |
|
3686
HF Foods Group
HFFG
$95.9M
| $101K | ﹤0.01% |
24,857
+13,658
| +122% | +$57.6K |
|
|
KRON
3687
DELISTED
Kronos Bio
KRON
| $101K | ﹤0.01% |
62,146
-1,423
| -2% | -$3.27K |
|
3688
Cardlytics
CDLX
$22.4M
| $100K | ﹤0.01% |
1,735
+9
| +0.5% | +$556 |
|
3689
Nano X Imaging
NNOX
$77.3M
| $99.4K | ﹤0.01% |
13,475
-171
| -1% | -$1.89K |
|
3690
Sundial Growers
SNDL
$323M
| $98.7K | ﹤0.01% |
47,225
-240
| -0.5% | -$571 |
|
|
HUT
3691
Hut 8
HUT
$10.9B
| $98.5K | ﹤0.01% |
23,181
+7,944
| +52% | +$59.9K |
|
|
LSEA
3692
DELISTED
Landsea Homes
LSEA
| $98.3K | ﹤0.01% |
+18,868
| New | +$98.4K |
|
|
FIRY
3693
Firy Inc
FIRY
$160M
| $97.9K | ﹤0.01% |
9,666
+8
| +0.1% | +$147 |
|
3694
Erasca
ERAS
$6.36B
| $97.6K | ﹤0.01% |
22,654
-127
| -0.6% | -$861 |
|
|
NGM
3695
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $97.6K | ﹤0.01% |
19,445
-42,458
| -69% | -$266K |
|
3696
C4 Therapeutics
CCCC
$476M
| $95.7K | ﹤0.01% |
16,226
-30
| -0.2% | -$249 |
|
|
CANO
3697
DELISTED
Cano Health, Inc.
CANO
| $95.7K | ﹤0.01% |
698
-60
| -8% | -$20.3K |
|
|
CLPR
3698
Clipper Realty
CLPR
$47M
| $95.7K | ﹤0.01% |
+14,951
| New | +$105K |
|
3699
Nuvation Bio
NUVB
$2.24B
| $94.6K | ﹤0.01% |
49,275
+130
| +0.3% | +$263 |
|
3700
Fulcrum Therapeutics
FULC
$282M
| $94.5K | ﹤0.01% |
12,978
+1,737
| +15% | +$11.3K |
|
Similar funds
Invesco's Q4 2022 Portfolio in Review
As of Q4 2022, Invesco held 4,129 positions worth $341B, up 9.9% from $311B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Invesco's Q4 2022 filing shows 147 new, 2,069 increased, 1,601 reduced and 115 closed positions. Its largest new stake was British American Tobacco: 3,556,143 shares worth $142M. The largest sale was UnitedHealth, an estimated $440M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2022 buy was British American Tobacco: 3,556,143 shares worth $142M.
- Invesco added most to NVIDIA in Q4 2022, an estimated $338M increase.
- Invesco's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $440M.
- Invesco fully exited Duke Realty Corp. in Q4 2022, selling an estimated $131M.
- Invesco's ten largest holdings make up 10% of its $341B portfolio in Q4 2022.
- Invesco opened 147 new positions and closed 115 in Q4 2022.
- Invesco's portfolio value rose 9.9% quarter-over-quarter to $341B.
Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.